Klotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway

References

• Maturo A, Tromba L, De Anna L, et al. Incidental thyroid carcinomas. A retrospective study. G Chir. 2017;38(2):94–101. doi:10.11138/gchir/2017.38.2.09428691675
   PubMed Web of Science ®Google Scholar
• Raue F, Frank-Raue K. Thyroid cancer: risk-stratified management and individualized therapy. Clin Cancer Res. 2016;22(20):5012–5021. doi:10.1158/1078-0432.ccr-16-048427742787
   PubMed Web of Science ®Google Scholar
• Elisei R, Pinchera A. Advances in the follow-up of differentiated or medullary thyroid cancer. Nat Rev Endocrinol. 2012;8(8):466–475. doi:10.1038/nrendo.2012.3822473335
   PubMed Web of Science ®Google Scholar
• Schweppe RE, Klopper JP, Korch C, et al. Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 2008;93(11):4331–4341. doi:10.1210/jc.2008-110218713817
   PubMed Web of Science ®Google Scholar
• Mencke R, Olauson H, Hillebrands JL. Effects of Klotho on fibrosis and cancer: a renal focus on mechanisms and therapeutic strategies. Adv Drug Deliv Rev. 2017;121:85–100. doi:10.1016/j.addr.2017.07.00928709936
   PubMed Web of Science ®Google Scholar
• Davidov B, Shmulevich R, Shabtay A, Rubinek T, Wolf I. The hormone KL1: a regulator of breast cancer cell metabolism. Isr Med Assoc J. 2019;21(7):504.31507133
   PubMedGoogle Scholar
• Arbel Rubinstein T, Shahmoon S, Zigmond E, et al. Klotho suppresses colorectal cancer through modulation of the unfolded protein response. Oncogene. 2019;38(6):794–807. doi:10.1038/s41388-018-0489-430232408
   PubMed Web of Science ®Google Scholar
• Fakhar M, Najumuddin N, Gul M, Rashid S. Antagonistic role of Klotho-derived peptides dynamics in the pancreatic cancer treatment through obstructing WNT-1 and Frizzled binding. Biophys Chem. 2018;240:107–117. doi:10.1016/j.bpc.2018.07.00230014891
   PubMed Web of Science ®Google Scholar
• Xuan NT, Hai NV. Changes in expression of klotho affect physiological processes, diseases, and cancer. Iran J Basic Med Sci. 2018;21(1):3–8.29372030
   PubMed Web of Science ®Google Scholar
• Pawlikowski M, Pisarek H, Borkowska M, Winczyk K. Expression of α-Klotho protein in human thyroid cancers - an immunohistochemical study. Endokrynol Pol. 2019;70(3):237–240. doi:10.5603/EP.a2019.000430699231
   PubMed Web of Science ®Google Scholar
• Nguyen VHL, Hough R, Bernaudo S, Peng C. Wnt/β-catenin signalling in ovarian cancer: insights into its hyperactivation and function in tumorigenesis. J Ovarian Res. 2019;12(1):122. doi:10.1186/s13048-019-0596-z31829231
   PubMed Web of Science ®Google Scholar
• Wang X, Lu X, Geng Z, Yang G, Shi Y. LncRNA PTCSC3/miR-574-5p governs cell proliferation and migration of papillary thyroid carcinoma via Wnt/β-catenin signaling. J Cell Biochem. 2017;118(12):4745–4752. doi:10.1002/jcb.2614228513866
   PubMed Web of Science ®Google Scholar
• Yu S, Cao S, Hong S, et al. miR-3619-3p promotes papillary thyroid carcinoma progression via Wnt/β-catenin pathway. Ann Transl Med. 2019;7(22):643. doi:10.21037/atm.2019.10.7131930044
   PubMed Web of Science ®Google Scholar
• Cheng X, Xu X, Chen D, Zhao F, Wang W. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer. Biomed Pharmacother. 2019;110:473–481. doi:10.1016/j.biopha.2018.11.08230530050
   PubMed Web of Science ®Google Scholar
• Krishnamurthy N, Kurzrock R. Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev. 2018;62:50–60. doi:10.1016/j.ctrv.2017.11.00229169144
   PubMed Web of Science ®Google Scholar
• Ye Y, Long X, Zhang L, et al. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma. Oncotarget. 2016;7(43):70303–70322. doi:10.18632/oncotarget.1185427611941
   PubMedGoogle Scholar
• Mao T, He C, Wu H, Yang B, Li X. Silencing lncRNA HOTAIR declines synovial inflammation and synoviocyte proliferation and promotes synoviocyte apoptosis in osteoarthritis rats by inhibiting Wnt/β-catenin signaling pathway. Cell Cycle. 2019;18(22):3189–3205. doi:10.1080/15384101.2019.167171631564232
   PubMed Web of Science ®Google Scholar
• Huang HM, Huang CC, Wang FS, Hung PL, Chang YC. Activating the Wnt/β-catenin pathway did not protect immature retina from hypoxic-ischemic injury. Invest Ophthalmol Vis Sci. 2015;56(8):4300–4308. doi:10.1167/iovs.14-1617626176867
   PubMed Web of Science ®Google Scholar
• Dai D, Wang Q, Li X, Liu J, Ma X, Xu W. Klotho inhibits human follicular thyroid cancer cell growth and promotes apoptosis through regulation of the expression of stanniocalcin-1. Oncol Rep. 2016;35(1):552–558. doi:10.3892/or.2015.435826531219
   PubMed Web of Science ®Google Scholar
• Raghav PK, Kumar R, Kumar V, Raghava GPS. Docking-based approach for identification of mutations that disrupt binding between Bcl-2 and Bax proteins: inducing apoptosis in cancer cells. Mol Genet Genom Med. 2019;7(11):e910. doi:10.1002/mgg3.910
   PubMed Web of Science ®Google Scholar
• Shim MK, Yoon HY, Lee S, et al. Caspase-3/-7-specific metabolic precursor for bioorthogonal tracking of tumor apoptosis. Sci Rep. 2017;7(1):16635. doi:10.1038/s41598-017-16653-229192289
   PubMed Web of Science ®Google Scholar
• Yu L, Meng W, Ding J, Cheng M. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway. Biochem Biophys Res Commun. 2016;473(2):455–461. doi:10.1016/j.bbrc.2016.03.02926970306
   PubMed Web of Science ®Google Scholar
• Tang X, Wang Y, Fan Z, et al. Klotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinoma. Lab Invest. 2016;96(2):197–205. doi:10.1038/labinvest.2015.8626237271
   PubMed Web of Science ®Google Scholar
• Sun H, Gao Y, Lu K, et al. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway. World J Surg Oncol. 2015;13:307. doi:10.1186/s12957-015-0717-026499380
   PubMed Web of Science ®Google Scholar